DPP4 and COVID-19: All three CHM formulas not only affect ACE but also blood sugar control related target proteins such as DPP4 and GHSR (Figure 1 and Figure 3), meaning that they can help reduce the risk of precipitating hyperglycemia caused by COVID-19 as well as lower the blood sugar level of pre-existing DM.